CAS 896731-82-1: Conatumumab
Fórmula:Unspecified
- Sinónimos:
- Conatumumab
- Immunoglobulin G1, anti-(human cytokine receptor DR5 (death receptor 5)) (human monoclonal XG1-048 v w heavy chain), disulfide with human monoclonal XG1-048 v w light chain, dimer
- Immunoglobulin G1, anti-(human TRAIL receptor 2) (human monoclonal XG1-048 v w heavy chain), disulfide with human monoclonal XG1-048 v w light chain, dimer
- AMG 655
- TRAIL-R2 mAb
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Conatumumab REF: TM-T76787CAS: 896731-82-1 | > 95% - > 95% | 359,00 €~1.454,00 € | Mié 16 Abr 25 |
 | Conatumumab REF: 3D-CLA1171CAS: 896731-82-1 | - - - | A consultar | Lun 28 Abr 25 |
Conatumumab
CAS:896731-82-1
Conatumumab (AMG 655) targets DR5 to induce apoptosis in tumors, with Kd of 1 nM …
Pureza:
> 95% - > 95%
Forma y color:
Liquid
Peso molecular:
145 kDa (average)
Ref: TM-T76787
| 1mg | 359,00 € | ||
| 5mg | 908,00 € | ||
| 10mg | 1.454,00 € |
Entrega estimada en Estados Unidos, el Miércoles 16 de Abril de 2025
Conatumumab
CAS:896731-82-1
A fully human monoclonal agonist antibody against the extracellular domain of human TRAIL.
Ref: 3D-CLA1171
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Lunes 28 de Abril de 2025
